glp 1 drugs and cholesterol Comparing Ozempic, Wegovy Other GLP-1 The Role of GLP-1RA Medications
Description
doi: 10.1038/304368a0 21 BellGISanterreRFMullenbachGT
Amgen is exploring novel biologics and peptide-based therapies, including GLP-1 receptor agonists, aiming to expand treatment options for obesity and diabetes
The A Study of Tirzepatide on the Reduction on Morbidity and Mortality in Adults with Obesity (SURMOUNT-MMO) trial assesses tirzepatide's impact on mortality and cardiovascular events in overweight or obese individuals
Long-term safety is under study
Additionally, gastrointestinal side effects (e.g
These molecules are also naturally resistant to the degradation of dipeptidyl peptidase-4 (DDP-4) enzymes
